Physician
Integrated Pain Solutions Incorporated
Integrated Pain Solutions Incorporated was paid $2.14M by Medicaid between Jul 2020 and Dec 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 52% of everything it billed.
33Billing provider infoINTEGRATED PAIN SOLUTIONS INCORPORATED
COLUMBUS, OH 43240
COLUMBUS, OH 43240
33aNPI1568639037assigned 05/13/2008
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$2.14M
24GClaims57,881
24DCodes billed30
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Ohio
Rank by total paid#3 of 43
Median peer was paid$52K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 8,363 | $265K | |
| 2021 | 13,718 | $504K | |
| 2022 | 11,438 | $427K | |
| 2023 | 11,574 | $455K | |
| 2024incomplete | 12,788 | $489K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 52% | 31,445 | 26,688 | $1.12M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 18% | 6,021 | 5,344 | $380K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 17% | 9,246 | 8,242 | $360K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.5% | 6,880 | 5,820 | $160K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 1,314 | 1,218 | $80K |
| 62323 | <1% | 70 | 64 | $9K | |
| 27096 | <1% | 64 | 44 | $6K | |
| 64493 | <1% | 64 | 53 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 72 | 62 | $4K |
| 64494 | <1% | 88 | 52 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 42 | 38 | $2K |
| 76942 | <1% | 80 | 65 | $2K |
18 more codes
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 673 | $2K |
| 80361 | <1% | 87 | $2K | |
| 62370 | <1% | 84 | $1K | |
| 80349 | <1% | 111 | $1K | |
| 80365 | <1% | 89 | $903.94 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 68 | $767.90 |
| 62369 | <1% | 31 | $698.75 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 148 | $638.47 |
| 99490 | Ccm add 20min | <1% | 246 | $417.78 |
| 80346 | <1% | 15 | $302.35 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 24 | $157.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 196 | $145.44 |
| J7999 | Compounded drug, not otherwise classified | <1% | 18 | $124.49 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 31 | $103.28 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 174 | $22.07 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 47 | $11.36 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 356 | $0.14 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 97 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOWLOWITZ, EDWARD (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Shadeland Anesthesia & Pain Associates INC. | Indianapolis, IN | $7.12M |
| Indiana Pain Centers-Evansville LLC | Evansville, IN | $224K |
| Center for Special Surgery LLC | Indianapolis, IN | $120K |
| Lafayette Surgery Center LLC | Lafayette, IN | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.